Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Go back to Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: IMUX) Delayed: 13.11 --0 (-0%)
Previous Close $13.11    52 Week High
Open $13.11    52 Week Low
Day High $13.11    P/E N/A 
Day Low $13.11    EPS
Volume 106